ArticlesAbstractPharmacognosy Research,2023,15,2,206-216.DOI:10.5530/pres.15.2.022Published:February 2023Type:Review ArticleAuthors:Medha Mohan Hegde, and K Lakshman Author(s) affiliations:Medha Mohan Hegde1,*, K Lakshman2 1Department of Pharmacognosy, Nargund College of Pharmacy, RGUHS, Bangalore, Karnataka, INDIA. 2Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, PES University, Bangalore, Karnataka, INDIA. Abstract:Natural drug-based chemotherapeutic have advanced at an unprecedented rate over the past decade. Owing to protective roles in vegetation, and exceptional antioxidant qualities, polyphenols and flavonoids have demonstrated promising clinical implications in malignancies amongst other plant metabolites. It is widely debated how dietary flavonoids and polyphenols can prevent cancer. Flavonoids are believed to execute a significant role in cancer prevention and treatment, as corroborated from experimental studies, epidemiological research, and human clinical trials. Carcinogen deactivation, antimutagenic, cell cycle arrest, apoptosis and differentiation, suppression of vasculature, oxidative stress, and reversion of multidrug resistance are among the many mechanisms of action that have been discovered. The present review outlines the classification of various polyphenols and flavonoids and their potential as anticancer therapeutic agents. Keywords:Cancer, Flavonoids, Polyphenols, Reactive oxygen species., Secondary metabolitesView:PDF (562.11 KB) PDF Thumbnails Document Outline Search Document Find Toggle Sidebar Previous Next Page: Fullscreen Print Download Current View Zoom Out Zoom In Automatic Zoom Actual Size Fit Page Full Width 50% 75% 100% 125% 150% 200% More Information Less Information Close Click here to download the PDF file. Images Anticancer properties of naturally occurring plant polyphenols. KeywordsCancerFlavonoidsPolyphenolsReactive oxygen species.Secondary metabolites ‹ Pharmacognosy Research, Vol 15, Issue 2, April-June, 2023 up Unexploited Potentials of Endophytic Fungi: Patents Review on Endophytic Fungi Related to Secondary Bioactive Compounds ›